Advanced search
Publication Cover
Minimally Invasive Therapy & Allied Technologies Volume 24, 2015 - Issue 4
Submit an article Journal homepage
155
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Anti Müllerian hormone levels before and after uterine artery embolization: A preliminary report

Bruce MclucasDepartment of Obstetrics and Gynecology, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USACorrespondence[email protected]
,
William D. Voorhees IIIMed Institute Inc, West Lafayette, IN, USA
&
Katherine Jane C. ChuaFibroid Treatment Collective, Beverly Hills, CA, USA
Pages 242-245 | Received 27 Jan 2014, Accepted 23 Dec 2014, Published online: 01 Mar 2015

References

  • Hehenkamp WJ, Volkers NA, Broekmans FJ, de Jong FH, Themmen AP, Birnie E, et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod. 2007;22:1996–2005.
  • Goldberg J, Pereira L, Berghella V. Pregnancy after uterine artery embolization. Obstet Gynecol. 2002;100:869–72.
  • Amato P, Roberts AC. Transient ovarian failure: a complication of uterine artery embolization. Fertil Steril. 2001;75:438–9.
  • Yeaton-Massey A, Loran M, Chetty S, Druzin M. Uterine rupture after uterine artery embolization for symptomatic leiomyomas. Obstet Gynecol. 2014;123:418–20.
  • Tulandi T, Sammour A, Valenti D, Child TJ, Seti L, Tan SL. Ovarian reserve after uterine artery embolization for leiomyomata. Fertil Steril. 2002;78:197–8.
  • McLucas B, Danzer H, Wambach C, Lee C. Ovarian reserve following uterine artery embolization in women of reproductive age: a preliminary report. Minim Invasive Ther Allied Technol. 2013;22:45–9.
  • Rashid S, Khaund A, Murray LS, Moss JG, Cooper K, Lyons D, et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. BJOG. 2010;117:985–9.
  • Goodwin SC, Spies JB. Uterine fibroid embolization. N Engl J Med. 2009;361:690–7.
  • Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19:340–7.
  • Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90:395–400.
  • Spies JB, Roth AR, Gonsalves SM, Murphy-Skrzyniarz KM. Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol. 2001;12:437–42.
  • Kaump GR, Spies JB. The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol. 2013;24:459–67.
  • Kim HS, Tsai J, Lee JM, Vang R, Griffith JG, Wallach EE. Effects of utero-ovarian anastomoses on basal follicle-stimulating hormone level change after uterine artery embolization with tris-acryl gelatin microspheres. J Vasc Interv Radiol. 2006;17:965–71.
  • de Vet A, Laven JSE, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357–62.
  • Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057–63.
  • Almog B, Shehala F, Suissa S, Holzer H, Shalom-Paz E, La Marca A, et al. Age-related normograms of serum antimullerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril. 2011;95:2359–63; 2363 e1.
  • van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int. 2003;14:525–30.
  • Firouznia K, Ghanaati H, Sanaai M, Jalali AH, Shakiba M. Pregnancy after uterine artery embolization for symptomatic fibroids: a series of 15 pregnancies. AJR Am J Roentgenol. 2009;192:1588–92.
  • Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;105:67–76.
  • Tropeano G, Di Stasi C, Litwicka K, Romano D, Draisci G, Manusco S. Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil Steril. 2004;81:1055–61.
  • Knauff EA, Eijkemans MJ, Lamballe CH, ten Kate-Booij MJ, Hoek A, Beerendonk CC, et al. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009;94:786–92.
  • Gnoth C, Schuring K, Friol J, Tigges P, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008;23:1359–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.